BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 10533799)

  • 1. T1762/A1764 variants of the basal core promoter of hepatitis B virus; serological and clinical correlations in Chinese patients.
    Hou J; Lau GK; Cheng J; Cheng CC; Luo K; Carman WF
    Liver; 1999 Oct; 19(5):411-7. PubMed ID: 10533799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of hepatitis B virus (HBV) genotypes and precore and core promoter mutations affecting HBV e antigen expression in Taiwan.
    Chen CH; Lee CM; Lu SN; Changchien CS; Eng HL; Huang CM; Wang JH; Hung CH; Hu TH
    J Clin Microbiol; 2005 Dec; 43(12):6000-6. PubMed ID: 16333089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Study on the distribution of hepatitis B virus precore and basic core promoter mutations in Guizhou area].
    Ding JJ; Liu YH; Wang M
    Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Feb; 28(2):169-72. PubMed ID: 17649690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Precore/core promoter mutations and genotypes of hepatitis B virus in chronic hepatitis B patients with fulminant or subfulminant hepatitis.
    Liu CJ; Kao JH; Lai MY; Chen PJ; Chen DS
    J Med Virol; 2004 Apr; 72(4):545-50. PubMed ID: 14981756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of hepatitis B virus base core and precore/core promoter mutations on hepatocellular carcinoma in untreated older genotype C Chinese patients.
    Zheng JX; Zeng Z; Zheng YY; Yin SJ; Zhang DY; Yu YY; Wang F
    J Viral Hepat; 2011 Oct; 18(10):e423-31. PubMed ID: 21914059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The prevalence and clinical significance of precore and core promoter mutations in Korean patients with chronic hepatitis B virus infection].
    Kim HJ; Yoo BC
    Taehan Kan Hakhoe Chi; 2002 Jun; 8(2):149-56. PubMed ID: 12499800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Basal core promoter T1762/A1764 and precore A1896 gene mutations in hepatitis B surface antigen-positive hepatocellular carcinoma: a comparison with chronic carriers.
    Tong MJ; Blatt LM; Kao JH; Cheng JT; Corey WG
    Liver Int; 2007 Dec; 27(10):1356-63. PubMed ID: 17900245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of core promoter mutations of hepatitis B virus and viral load is different in HBeAg(+) and HBeAg(-) patients.
    Utama A; Siburian MD; Purwantomo S; Intan MD; Kurniasih TS; Gani RA; Achwan WA; Arnelis ; Lelosutan SA; Lukito B; Harmono T; Zubir N; Julius ; Soemohardjo S; Lesmana LA; Sulaiman A; Tai S
    World J Gastroenterol; 2011 Feb; 17(6):708-16. PubMed ID: 21390140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of mutations in core promoter/precore region in Japanese patients with chronic hepatitis B virus infection.
    Nagasaka A; Hige S; Marutani M; Tsunematsu I; Saito M; Yamamoto Y; Konishi S; Asaka M
    Dig Dis Sci; 1998 Nov; 43(11):2473-8. PubMed ID: 9824137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The precore/core promoter mutant (T1762A1764) of hepatitis B virus: clinical significance and an easy method for detection.
    Takahashi K; Aoyama K; Ohno N; Iwata K; Akahane Y; Baba K; Yoshizawa H; Mishiro S
    J Gen Virol; 1995 Dec; 76 ( Pt 12)():3159-64. PubMed ID: 8847524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene heterogeneity of hepatitis B virus isolates from patients with severe hepatitis B.
    Wu W; Chen Y; Ruan B; Li LJ
    Hepatobiliary Pancreat Dis Int; 2005 Nov; 4(4):530-4. PubMed ID: 16286257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance and evolution of core promoter and precore mutations in HBeAg-positive patients with HBV genotype B and C: a longitudinal study.
    Chen CH; Lee CM; Hung CH; Hu TH; Wang JH; Wang JC; Lu SN; Changchien CS
    Liver Int; 2007 Aug; 27(6):806-15. PubMed ID: 17617124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basal core promoter mutations of hepatitis B virus increase the risk of hepatocellular carcinoma in hepatitis B carriers.
    Kao JH; Chen PJ; Lai MY; Chen DS
    Gastroenterology; 2003 Feb; 124(2):327-34. PubMed ID: 12557138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific mutations in the enhancer II/core promoter/precore regions of hepatitis B virus subgenotype C2 in Korean patients with hepatocellular carcinoma.
    Kim JK; Chang HY; Lee JM; Baatarkhuu O; Yoon YJ; Park JY; Kim DY; Han KH; Chon CY; Ahn SH
    J Med Virol; 2009 Jun; 81(6):1002-8. PubMed ID: 19382267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virological and clinical implication of core promoter C1752/V1753 and T1764/G1766 mutations in hepatitis B virus genotype D infection in Mongolia.
    Elkady A; Tanaka Y; Kurbanov F; Oynsuren T; Mizokami M
    J Gastroenterol Hepatol; 2008 Mar; 23(3):474-81. PubMed ID: 18318825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of genotypes C and D of the hepatitis B virus in Japan: a clinical and molecular biological study.
    Duong TN; Horiike N; Michitaka K; Yan C; Mizokami M; Tanaka Y; Jyoko K; Yamamoto K; Miyaoka H; Yamashita Y; Ohno N; Onji M
    J Med Virol; 2004 Apr; 72(4):551-7. PubMed ID: 14981757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolution of precore/core promoter mutations in hepatitis B carriers with hepatitis B e antigen seroreversion.
    Liu CJ; Chen PJ; Lai MY; Kao JH; Chen DS
    J Med Virol; 2004 Oct; 74(2):237-45. PubMed ID: 15332272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of hepatitis B viral load and basal core promoter mutation in hepatocellular carcinoma in hepatitis B carriers.
    Liu CJ; Chen BF; Chen PJ; Lai MY; Huang WL; Kao JH; Chen DS
    J Infect Dis; 2006 May; 193(9):1258-65. PubMed ID: 16586363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B e antigen-negative mutations in the precore and core promoter regions in Korean patients.
    Choi JW; Ahn SH; Park JY; Chang HY; Kim JK; Baatarkhuu O; Kim DY; Han KH; Chon CY
    J Med Virol; 2009 Apr; 81(4):594-601. PubMed ID: 19235871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of sequence changes of precore and core promoter regions in HBeAg-positive chronic hepatitis B patients with and without HBeAg clearance in lamivudine therapy.
    Chen CH; Lee CM; Lu SN; Changchien CS; Wang JC; Wang JH; Hung CH; Hu TH
    J Hepatol; 2006 Jan; 44(1):76-82. PubMed ID: 16298013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.